Baran, Amprose .
HRN: 14-13-84 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
CEFUROXIME 500MG (TAB)
01/09/2024
01/16/2024
ORAL
500mg
BID
NSVD With Right Mediolateral Episiorrhapy
Checking Final Appropriateness